These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11080517)
21. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain. Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964 [TBL] [Abstract][Full Text] [Related]
22. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices. Monnet FP; de Costa BR; Bowen WD Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358 [TBL] [Abstract][Full Text] [Related]
32. Dissociation of guanosine 5'-[gamma-thio]triphosphate from guanine-nucleotide-binding regulatory proteins in native cardiac membranes. Regulation by nucleotides and muscarinic acetylcholine receptors. Hilf G; Kupprion C; Wieland T; Jakobs KH Eur J Biochem; 1992 Mar; 204(2):725-31. PubMed ID: 1541285 [TBL] [Abstract][Full Text] [Related]
33. Binding properties of SA4503, a novel and selective sigma 1 receptor agonist. Matsuno K; Nakazawa M; Okamoto K; Kawashima Y; Mita S Eur J Pharmacol; 1996 Jun; 306(1-3):271-9. PubMed ID: 8813641 [TBL] [Abstract][Full Text] [Related]
34. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists. Izenwasser S; Thompson-Montgomery D; Deben SE; Chowdhury IN; Werling LL Eur J Pharmacol; 1998 Apr; 346(2-3):189-96. PubMed ID: 9652359 [TBL] [Abstract][Full Text] [Related]
35. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding. Malmberg ; Mikaels ; Mohell N J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001 [TBL] [Abstract][Full Text] [Related]
36. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes. Odagaki Y; Toyoshima R Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659 [TBL] [Abstract][Full Text] [Related]
37. mu-Opioid receptor-stimulated guanosine-5'-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Selley DE; Sim LJ; Xiao R; Liu Q; Childers SR Mol Pharmacol; 1997 Jan; 51(1):87-96. PubMed ID: 9016350 [TBL] [Abstract][Full Text] [Related]
38. Determination of [35S]guanosine-5'-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay. DeLapp NW; McKinzie JH; Sawyer BD; Vandergriff A; Falcone J; McClure D; Felder CC J Pharmacol Exp Ther; 1999 May; 289(2):946-55. PubMed ID: 10215674 [TBL] [Abstract][Full Text] [Related]
39. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects. Szekeres PG; Traynor JR J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003 [TBL] [Abstract][Full Text] [Related]
40. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain. Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]